Biopharmaceutical preparations for human use containing plasma-derived proteins and recombinant, transgenic, or other synthetic equivalents therefore for use in the medical treatment of hemophilia and immune deficiency diseases as well as those in critical care situations such as burns and shock where restoration of blood volume is key and also for the treatment of healing wounds
Pharmaceuticals